IPO Traffic: Week Ending March 13, 2015

  Lead Manager/ # of Price Range   Dollar SCOOP
New Filings (Proposed Symbol) Joint-Lead Managers Shares Low High Volume Ratings
8point3 Energy Partners LP  (TBA) Goldman Sachs/ Citigroup $50.00 n.a.
Aduro Biotech  (ADRO) BofA Merrill Lynch/ Leerink Partners $86.25 n.a.
Cidara Therapeutics  (CDTX) Jefferies/ Leerink Partners $69.00 n.a.
KemPharm   (KMPH) Cowen and Company/ RBC Capital Markets $57.50 n.a.
Par Pharmaceutical (PRX)
J.P. Morgan/ Goldman Sachs $100.00 n.a.
n.a. (not available)
 
Postponed
None
 
Withdrawn
AltheaDx  (IDGX) Citigroup/ Jefferies 4.62 $12.00 $14.00 $60.00 1-Star
 
New Terms
Arowana (ARWAU) (u) EarlyBirdCapital 7.20 $10.00 $10.00 $72.00 1-Star
Goldman Sachs BDC (GSBD) BofA Merrill Lynch/ Goldman Sachs/ Morgan Stanley/ Citigroup/ Credit Suisse/ Wells Fargo Securities 6.00 $20.00 $21.00 $123.00 2-Stars
Jernigan Capital (JCAP) Raymond James/ Baird/ Wunderlich Securities 5.00 $19.00 $21.00 $100.00 n.a.
National Commerce  (NCOM) Keefe, Bruyette & Woods (A Stifel Company) 1.60 $18.50 $20.50 $31.20 2-Stars
SolarEdge Technologies (SEDG) Goldman Sachs/ Deutsche Bank Securities 7.00 $16.00 $18.00 $119.00 n.a.
SteadyMed (STDY) Wells Fargo Securities/ RBC Capital Markets 4.25 $12.00 $14.00 $55.25 1-Star
Valeritas (VLRX) Piper Jaffray/ Leerink Partners 5.00 $14.00 $16.00 $75.00 1-Star
ViewRay (VRAY) Cowen and Company/ Stifel 4.00 $12.00 $14.00 $52.00 n.a.
Xbiotech (XBIT) WR Hambrecht + Co 4.00 $18.00 $20.00 $76.00 N/C
N/C = No Call – deal is a “best effort” offering          
             
IPOs Priced Lead Shares Amount Offer Close %
Week of March 9, 2015 Manager(s) Offered Raised Price 3/13/15 Change
Summit Materials   (SUM) Citigroup/ Goldman Sachs/ BofA Merrill Lynch/ Barclays/ Deutsche Bank Securities/ RBC Capital Markets 22.22 $400.00 $18.00 $21.00 16.67%